Workflow
CODI DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Compass Diversified Holdings Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CODI
GlobeNewswire News Room· 2025-06-13 17:05
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between May 1, 2024, and May 7, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Compass securities you may be entitled to compensation without payment of any out of pocket fees or costs through a ...
These Analysts Revise Their Forecasts On Adobe Following Q2 Results
Benzinga· 2025-06-13 17:04
Core Insights - Adobe Inc. reported second-quarter revenue of $5.87 billion, exceeding analyst estimates of $5.79 billion, and adjusted earnings of $5.06 per share, surpassing the expected $4.96 per share [1][2] - The company raised its full-year 2025 revenue guidance to a range of $23.5 to $23.6 billion, up from the previous guidance of $23.3 billion to $23.55 billion, and adjusted earnings guidance to $20.50 to $20.70 per share, increased from $20.20 to $20.50 per share [3] Financial Performance - For the third quarter, Adobe expects revenue between $5.88 billion and $5.93 billion, compared to estimates of $5.87 billion, and anticipates adjusted earnings of $5.15 to $5.20 per share, against estimates of $5.10 per share [2] - Following the earnings announcement, Adobe shares fell by 5.8% to $389.64 [3] Analyst Ratings and Price Targets - Wells Fargo analyst Michael Turrin maintained an Overweight rating and raised the price target from $430 to $470 [6] - Oppenheimer analyst Brian Schwartz maintained an Outperform rating but lowered the price target from $530 to $500 [6] - Evercore ISI Group analyst Kirk Materne reiterated an Outperform rating with a maintained price target of $475, while BMO Capital analyst Keith Bachman also reiterated an Outperform rating with a price target of $450 [6]
Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results
Seeking Alpha· 2025-06-13 17:02
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. This article is intended to provide informational content and should not be viewed as an exhaustive an ...
Block vs. Upstart: Which Fintech Stock Has More Upside in 2025?
ZACKS· 2025-06-13 17:01
Key Takeaways Block is expanding Square and Cash App, but faces macro pressures and slowing discretionary spending. Upstart's AI-driven lending saw 67% revenue growth and a shift to profitability in Q1 2025. While XYZ trades cheaper, UPST's expanding credit portfolio and AI upgrades drive upside potential.The fintech sector is evolving fast, driven by innovation in digital payments, credit underwriting, and user experience. Two major players — Block, Inc. (XYZ) and Upstart Holdings (UPST) — stand out for ...
Crown (CCK) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-06-13 17:01
Crown Holdings (CCK) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The ...
What Makes Verve Therapeutics (VERV) a New Buy Stock
ZACKS· 2025-06-13 17:01
Investors might want to bet on Verve Therapeutics (VERV) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changi ...
What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
ZACKS· 2025-06-13 17:01
Adaptive Biotechnologies (ADPT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individua ...
All You Need to Know About Dun & Bradstreet (DNB) Rating Upgrade to Buy
ZACKS· 2025-06-13 17:01
Dun & Bradstreet (DNB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a ch ...
Lyft (LYFT) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-06-13 17:01
Lyft (LYFT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings picture is a ...
Huntington Ingalls (HII) Upgraded to Buy: Here's Why
ZACKS· 2025-06-13 17:01
Investors might want to bet on Huntington Ingalls (HII) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power o ...